Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial

Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page shows a revision tag updated to v3.6.6, replacing the previous v3.6.5. This indicates a small version update with no apparent changes to the visible content or study information.
    Difference
    0.1%
    Check dated 2026-08-29T21:55:05.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, replacing Revision: v3.6.4. This indicates a small update to the study record on ClinicalTrials.gov without altering the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:45:29.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The revision tag updated from v3.6.3 to v3.6.4, indicating a new build or update to the page's backend/content.
    Difference
    0.1%
    Check dated 2026-07-25T17:30:11.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the documentation.
    Difference
    0.1%
    Check dated 2026-07-04T13:09:21.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or user-facing content appears to be altered.
    Difference
    0.1%
    Check dated 2026-06-27T07:39:48.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Results posting details were added to the record, indicating that results were posted on 2026-06-16 with associated outcome descriptions and a linked Study Protocol and Statistical Analysis Plan PDF. The reported number of patients with dose modification due to toxicity was updated to 73 (from 75).
    Difference
    2%
    Check dated 2026-06-20T05:29:49.000Z thumbnail image

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.